Crovalimab (Anti-Complement C5)
Product Specifications
CAS Number
1917321-26-6
Synonyms
SKY59; RO7112689
Target
Complement System
Applications
Immunology & Inflammation
Additionnal Information
Crovalimab (Anti-Complement C5) is a humanized recycling monoclonal antibody directed against the complement pathway protein C5, with potential complement pathway inhibitory and immunomodulating activities. MW : 145.28 KD.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS6357117-01 0.1 mL
TNIP2, ID (TNIP2, ABIN2, FLIP1, TNFAIP3-interacting protein 2, A20-binding inhibitor of NF-kappa-B activation 2, Fetal liver LKB1-interacting protein) (MaxLight 650)
Sign In for Pricing
View Details MBS6357117-02 5x 0.1 mL
TNIP2, ID (TNIP2, ABIN2, FLIP1, TNFAIP3-interacting protein 2, A20-binding inhibitor of NF-kappa-B activation 2, Fetal liver LKB1-interacting protein) (MaxLight 650)
Sign In for Pricing
View Details 
MBS1034273-01 0.02 mg (E-Coli)
Recombinant Orientia tsutsugamushi NADH-quinone oxidoreductase subunit D (nuoD)
Sign In for Pricing
View Details MBS1034273-02 0.02 mg (Yeast)
Recombinant Orientia tsutsugamushi NADH-quinone oxidoreductase subunit D (nuoD)
Sign In for Pricing
View Details